Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-16-011405
Filing Date
2016-01-08
Accepted
2016-01-08 17:06:31
Documents
1
Period of Report
2016-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 5821
  Complete submission text file 0000899243-16-011405.txt   7051
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Adams Brian (Reporting) CIK: 0001636994 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-30929 | Film No.: 161333951